Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis
References (34)
- et al.
for the Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes (TEMPO) study investigators
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial. Lancet
(2004) - et al.
Early versus delayed treatment in patients with recentonset rheumatoid arthritis: Comparison of two cohorts who received different treatment strategies
Am J Med
(2001) - et al.
A checklist for medication compliance and persistence studies using retrospective databases
Value Health
(2007) - et al.
Persistence with bisphosphonate treatment for osteoporosis: Finding the root of the problem
Am J Med
(2006) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
J Chronic Dis
(1987) - et al.
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
J Clin Epidemiol
(1992) - et al.
Projected patterns of compliance associated with Remicade (infliximab) and Enbrel (etanercept)
J Rheumatol
(2002) - et al.
Treatment compliance and dosage administration among rheumatoid arthritis patients receiving inflixi mab, etanercept, or methotrexate
Am J Manag Care
(2003) - et al.
Reading and interpreting economicevaluations in rheumatoid arthritis: An assessment of selected instruments for critical appraisal
J Rheumatol
(2003) - et al.
for the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med
(2000)
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
Arthritis Rheum
(2004)
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
Ann Rheum Dis
(2006)
Enbrel (etanercept) [package insert]
(2006)
Remicade (infliximab) [package insert]
(2007)
Humira (adalimumab) [package insert]
(2006)
Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis
Rheumatology (Oxford)
(2004)
Economic issues with new rheumatologic therapeutics
Curr Opin Rheumatol
(2007)
Cited by (0)
Results of this study were presented in part at the 12th Annual International Meeting of the International Society of Pharmacoeconomics and Outcome Research, May 19-23, 2007, Arlington, Va; and the 19th Annual Meeting and Showcase of the Academy of Managed Care Pharmacy, April 11-14, 2007, San Diego, Calif.
Copyright © 2008 Published by Elsevier Inc.